All News

Want to Go Far, Go Together (4.21.2023)

Save

d Jack Cush, MD

Apr 21, 2023

This week on the podcast Dr. Jack Cush reviews the news, regulatory announcements and novel journal reports including a profile on pseudogout, the safety of immune checkpoint inhibitors in RA patients and the diagnostic importance of neutrophils.

Read Article

Aging Mechanisms Tied to Giant Cell Arteritis

Save

d MedPage Today

Apr 20, 2023

Senescence pathways are involved in giant cell arteritis (GCA), an analysis of patient tissue samples suggested, which may account for the efficacy of one agent now used for the disease and another in commercial development.

Read Article

The Power of Collaboration: Building Relationships to Amplify Your Impact and Have More Fun

Save

d Jinoos Yazdany, MD, MPH

Apr 20, 2023

Collaboration has proven to be an essential ingredient for progress and innovation in rheumatology. Effective collaboration requires generosity with your time and resources. Here are some things that I’ve learned over the years about successful collaborations in rheumatology.

Read Article

Sex-Specific Differences in Psoriatic Arthritis

Save

d Jack Cush, MD

Apr 19, 2023

A systematic review of published literature on psoriatic arthritis (PsA), clinical features, disease activity, and patient-reported outcomes (PROs) shows generally higher levels of disease activity in women, compared to men with PsA.

Read Article

Amgen Wins Otezla Patent Case - Brand Protected till 2028

Save

d Reuters

Apr 19, 2023

Amgen Inc convinced a U.S. appeals court on Wednesday to uphold patents that bar generic versions of its blockbuster psoriasis drug Otezla proposed by Zydus Pharmaceuticals and Novartis AG's Sandoz Inc until 2028.

Read Article

TNR: Private Practice & Academia

Save

d Kathryn H. Dao, M.D.

Apr 19, 2023

In this session, our panelists addressed the big questions of: "How do I choose between private practice and academia?" and "How do I advance in my career?".

Read Article

Renal Function Safe With Pegloticase-MTX Combo for Gout

Save

d MedPage Today

Apr 18, 2023

For patients with uncontrolled gout, estimated glomerular filtration rate (eGFR) remained stable with combination pegloticase (Krystexxa) and methotrexate treatment, researchers reported.

Read Article

CIRCS study: Comparison of 3188 Gout (733 M: 355 F) and ~10K non-gout. Found that the risk of gout in men linked to HTN (HR 1.41)and alcohol (HR 1.23 & 1.41), but that only smoking was a risk factor among women (HR 1.66). https://t.co/ODQW3SUjet https://t.co/Y8FTpbeXd5

Links:

https://bit.ly/41sfxMu

Dr. John Cush RheumNow ( View Tweet)

Apr 20, 2023

NIH sponsored nationwide survey assessed 1,462 SLE pts (9% men; 81% women). Male SLE pts had more MI & difficultly w/ medical forms than F. Female SLE had more fatiguer and higher educational levels. Both had barriers to health care access (40-47%) https://t.co/A0Zv5IvXnh https://t.co/BFMspCs6yE

Links:

https://bit.ly/3UQGyXF

Dr. John Cush RheumNow ( View Tweet)

Apr 20, 2023

CDC defines Health equity as a state where everyone has a fair & just opportunity to attain their highest level of health; requires efforts to: address injustices; overcome economic;social obstacles to health & eliminate preventable health disparities https://t.co/fYviqSBIse https://t.co/XuRZ4xJdXH

Links:

https://bit.ly/40r3xte

Dr. John Cush RheumNow ( View Tweet)

Apr 20, 2023

Renal Function Safe With Pegloticase-MTX Combo for Gout For patients with uncontrolled gout, estimated glomerular filtration rate (eGFR) remained stable with combination pegloticase (Krystexxa) and methotrexate treatment, researchers reported. https://t.co/cInxAUrQiR https://t.co/MoBKUMKfjP

Links:

https://bit.ly/3mGvf7T

Dr. John Cush RheumNow ( View Tweet)

Apr 20, 2023

Women Rheumatologists Leading in the Private Sector There are many opportunities outside of academic medicine to flex your leadership muscle. https://t.co/Ifusp8Crvf https://t.co/JMDjhzffOP

Links:

https://bit.ly/3AckVHF

Dr. John Cush RheumNow ( View Tweet)

Apr 20, 2023

JAMA Dermatology Patient Education page - Sarcoidosis of the Skin https://t.co/aPbTjl3pXv https://t.co/wCbjlUeFkj

Links:

https://bit.ly/3Awaxed

Dr. John Cush RheumNow ( View Tweet)

Apr 20, 2023

Join us as we conclude our Women in Rheumatology campaign by focusing on what's next. Our panelists will recap the challenges addressed this month and discuss a strategy to continue supporting women in rheumatology. https://t.co/ofr1tt90TO @uptoTate @KDAO2011 @gwenesta_melton https://t.co/YNr6gnS5Sf

Links:

https://bit.ly/43WsU9A

Dr. John Cush RheumNow ( View Tweet)

Apr 19, 2023

Dr. Megan E.B. Clowse discusses the differences in pregnancy planning for men and women with rheumatic disesase. https://t.co/KLyrGbYzJc https://t.co/E2Ep6BqvBN

Links:

https://bit.ly/3A99SPs

Dr. John Cush RheumNow ( View Tweet)

Apr 19, 2023

Immune Checkpoint Inhibitor Safety with Pre-existing Rheumatoid Arthritis Lancet Rheumatology has published a retrospective analysis showing patients receiving ICI for cancer have the same outcomes even when they have pre-existing RA. https://t.co/Tjj827nPTT https://t.co/nBBgI9wpjR

Links:

https://bit.ly/43J9vZy

Dr. John Cush RheumNow ( View Tweet)

Apr 19, 2023

Brigham review (2018-2022) of 47 CPPD pts: M=F, mean age 72 yrs 68% w/ acute CPP arthritis 40% w/ CPP inflammatory arthritis 62% w/ OA with CPPD. Compared to Gout, CPPD Significant unmet Rx need & lower RAPID3 (8.1 vs 12.1) https://t.co/nFOW4FS0fp https://t.co/3n6WTg66r8

Links:

https://bit.ly/41FFnfH

Dr. John Cush RheumNow ( View Tweet)

Apr 19, 2023

What do we know about gender equity in academic rheumatology? Dr. Nicola Dalbeth (@NicolaDalbeth) shares her thoughts. https://t.co/ha4UvqEygk https://t.co/tmGhFUW09t

Links:

https://bit.ly/3LduPPJ

Dr. John Cush RheumNow ( View Tweet)

Apr 19, 2023

RheumThoughts: The Benefits of Networking Dr. Rachel Tate ( @uptoTate ) discusses the importance and benefits of networking. RheumThoughts are opinion pieces from healthcare professionals in the RheumNow network. https://t.co/Ug3N4F4CGI https://t.co/vpXSsrlCcd

Links:

https://bit.ly/3L5iYTJ

Dr. John Cush RheumNow ( View Tweet)

Apr 18, 2023

6 specialties saw a pay drop in 2023 - #6 on the list was Rheumatology at -3% (based on Medscape survey of 10,011 physicians 1022-1/23. Biggest drop was Ophthalmology -7% (then EM -6%, PM&R -5%, Nephrology -5%, Allergy -5%, RHEUM -3%) https://t.co/9P7ujh2Tw0 https://t.co/8DaGUsrROY

Links:

https://bit.ly/40gwmsg

Dr. John Cush RheumNow ( View Tweet)

Apr 18, 2023

Topics

All News

Want to Go Far, Go Together (4.21.2023)

Save

Aging Mechanisms Tied to Giant Cell Arteritis

Save

The Power of Collaboration: Building Relationships to Amplify Your Impact and Have More Fun

Save

Sex-Specific Differences in Psoriatic Arthritis

Save

Amgen Wins Otezla Patent Case - Brand Protected till 2028

Save

TNR: Private Practice & Academia

Save

Renal Function Safe With Pegloticase-MTX Combo for Gout

Save

Do you get our email newsletter?

Want to Go Far, Go Together (4.21.2023) Save

Aging Mechanisms Tied to Giant Cell Arteritis Save

The Power of Collaboration: Building Relationships to Amplify Your Impact and Have More Fun Save

Sex-Specific Differences in Psoriatic Arthritis Save

Amgen Wins Otezla Patent Case - Brand Protected till 2028 Save

TNR: Private Practice & Academia Save

Renal Function Safe With Pegloticase-MTX Combo for Gout Save

Want to Go Far, Go Together (4.21.2023)

Save

Aging Mechanisms Tied to Giant Cell Arteritis

Save

The Power of Collaboration: Building Relationships to Amplify Your Impact and Have More Fun

Save

Sex-Specific Differences in Psoriatic Arthritis

Save

Amgen Wins Otezla Patent Case - Brand Protected till 2028

Save

TNR: Private Practice & Academia

Save

Renal Function Safe With Pegloticase-MTX Combo for Gout

Save